Previous close | 0.0000 |
Open | 0.0400 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0400 - 0.0400 |
52-week range | 0.0400 - 0.4000 |
Volume | |
Avg. volume | 0 |
Market cap | 117.67M |
Beta (5Y monthly) | 1.57 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings date | 30 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With the business potentially at an important milestone, we thought we'd take a closer look at CardieX Limited's...
Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure—an important indicator of heart health—using a noninvasive fingertip sensor. The study, co-authored by Cardiex's team, was published in the respected journal Pulse.